A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
Mefenamic acid, a common anti-inflammatory drug already approved for pain management ... who are exposed to very small doses of this medication. Mefenamic acid is already available in a generic ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...